Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Checkpoint Therapeutics, Inc.

NASDAQ: CKPTHealthcare / Biotechnology / -
2.16-0.09-4.00%Vol 1 1771Y Perf -60.64%
Dec 10th, 2018 11:28
BID2.16 ASK2.20
Open2.22 Previous Close2.26
Pre-Market- After-Trading-
 - -%  - -%
Target Price
15.50 
Analyst Rating
Strong Buy 1.00
Potencial %
617.59 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)74 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
6.14 
Earnings Date
2nd Nov 2018

Today's Price Range

2.162.22

 

52wk Range

1.896.29

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-2.17%
3 Months
-46.04%
6 Months
-26.95%
1 Year
-60.64%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CKPT2.16-0.0900-4.00
AAPL165.00-3.4900-2.07
GOOG1 033.05-3.5300-0.34
MSFT104.66-0.1600-0.15
XOM75.04-2.6000-3.35
WFC48.51-1.7500-3.48
JNJ142.88-2.5500-1.75
FB140.162.74001.99
GE6.81-0.2000-2.85
JPM99.85-3.4400-3.33
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.40
Current Ratio
3.50
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-3 802.90
EBITDA Margin
-3 802.90
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
5.59
PS Ratios
97.88
Price to Cash Flow
-
Price to Free Cash Flow
-6.30
Cash Flow Per Share
-0.79
Price to Tangible Book
5.59
Book Value per Share
0.69
Enterprise Value (in ths.)
96 275
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-146.60
Return on Assets (5Y Avg)
-
ROA last 12 Months
-108.63
Return on Capital (5Y Avg)
-
ROC last 12 Months
-147.18
Return on invested Capital Q
-42.36
Return on invested Capital Y
-96.21
Assets Turnover
0.00
Receivables Turnover
0.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
807
Revenue per Share
0.03
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.22-0.32-45.45
Q02 2018-0.35-0.2334.29
Q01 2018-0.19-0.35-84.21
Q04 2017-0.27-0.263.70
Q02 2017--0.28-
----
----
----
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.25-13.64Negative
12/2018 QR-0.2233.33Positive
12/2018 FY-1.20-17.65Negative
12/2019 FY-1.15-6.48Negative
Next Report Date-
Estimated EPS Next Report-0.22
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume1 177
Shares Outstanding (in ths.)34 050
Trades Count0
Dollar Volume0
Avg. Volume87 847
Avg. Weekly Volume52 295
Avg. Monthly Volume49 154
Avg. Quarterly Volume114 935

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

62%38%

Bearish Bullish

33%67%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News